N-((6-amino-2-methylpyridin-3-yl)methyl)-2-(3-(3-chloro-2-methylphenylsulfonamido)-2-hydroxy-6-methylphenyl)acetamide hydrochloride

ID: ALA556953

Chembl Id: CHEMBL556953

PubChem CID: 45263358

Max Phase: Preclinical

Molecular Formula: C23H26Cl2N4O4S

Molecular Weight: 489.00

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NS(=O)(=O)c2cccc(Cl)c2C)c(O)c1CC(=O)NCc1ccc(N)nc1C.Cl

Standard InChI:  InChI=1S/C23H25ClN4O4S.ClH/c1-13-7-9-19(28-33(31,32)20-6-4-5-18(24)14(20)2)23(30)17(13)11-22(29)26-12-16-8-10-21(25)27-15(16)3;/h4-10,28,30H,11-12H2,1-3H3,(H2,25,27)(H,26,29);1H

Standard InChI Key:  SSFHJTZONAIWEM-UHFFFAOYSA-N

Associated Targets(Human)

F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin & trypsin (271 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRSS1 Tclin Trypsin (2137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 489.00Molecular Weight (Monoisotopic): 488.1285AlogP: 3.61#Rotatable Bonds: 7
Polar Surface Area: 134.41Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 6.92CX Basic pKa: 7.54CX LogP: 3.22CX LogD: 3.27
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.38Np Likeness Score: -1.34

References

1. Hanessian S, Therrien E, van Otterlo WA, Bayrakdarian M, Nilsson I, Fjellström O, Xue Y..  (2006)  Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure.,  16  (4): [PMID:16290930] [10.1016/j.bmcl.2005.10.082]

Source